Cadre (NYSE:CDRE – Free Report) had its price objective lowered by Roth Mkm from $39.00 to $37.00 in a research report sent to investors on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.
Cadre Stock Up 2.7 %
CDRE traded up $0.93 during trading on Thursday, reaching $34.93. The company had a trading volume of 234,631 shares, compared to its average volume of 229,434. The business’s fifty day moving average price is $36.92 and its 200 day moving average price is $34.92. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.17 and a quick ratio of 2.14. Cadre has a 12 month low of $28.46 and a 12 month high of $40.28. The company has a market cap of $1.42 billion, a P/E ratio of 33.00, a PEG ratio of 2.08 and a beta of 1.30.
Cadre (NYSE:CDRE – Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.02. The firm had revenue of $109.41 million for the quarter, compared to the consensus estimate of $126.27 million. Cadre had a return on equity of 17.45% and a net margin of 7.55%. The company’s revenue for the quarter was down 12.6% on a year-over-year basis. During the same quarter last year, the business posted $0.29 EPS. Equities analysts anticipate that Cadre will post 1.04 EPS for the current year.
Cadre Dividend Announcement
Institutional Investors Weigh In On Cadre
Several institutional investors and hedge funds have recently added to or reduced their stakes in CDRE. Harel Insurance Investments & Financial Services Ltd. increased its position in shares of Cadre by 454.3% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,624 shares of the company’s stock valued at $55,000 after acquiring an additional 1,331 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of Cadre during the 2nd quarter worth approximately $141,000. Susquehanna Fundamental Investments LLC bought a new stake in shares of Cadre during the 1st quarter worth approximately $225,000. Truist Financial Corp acquired a new stake in shares of Cadre in the 2nd quarter valued at approximately $209,000. Finally, Oppenheimer Asset Management Inc. bought a new position in shares of Cadre in the second quarter valued at $216,000. 43.95% of the stock is owned by institutional investors.
Cadre Company Profile
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Stories
- Five stocks we like better than Cadre
- What Is WallStreetBets and What Stocks Are They Targeting?
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.